A novel feedback regulatory mechanism operating on transcription of the albumin gene is described in the rat. In 1946, it was proposed that circulating colloids, including serum albumin, may affect the synthesis and/or secretion ofalbumin in the liver. The molecular basis for this proposed regulation has now been investigated by adding oncotically active macromolecules to the circulation of normal or genetically albumin-deficient Nagase analbuminemic rats (NAR) and analyzing the hepatic expression of genes, including albumin after 24 h. The transcription rate of the albumin gene was higher in NAR than in normal rats and was dramatically reduced by raising serum albumin to 1.6 g/dl. Intravenous infusion of albumin into normal rats also decreased transcriptional activity of the albumin gene by 50-60%, and this decrease correlated with changes in serum colloid osmotic pressure after albumin infusion. Inhibition ofalbumin gene transcription was also observed upon intravenous infusion of other protein or nonprotein macromolecules, such as y-globulin and dextran. This down-regulation appears to control the steady-state level of albumin mRNA in the liver.
Introduction
A novel feedback regulatory mechanism operating on transcription of the albumin gene is described in the rat. In 1946, it was proposed that circulating colloids, including serum albumin, may affect the synthesis and/or secretion ofalbumin in the liver. The molecular basis for this proposed regulation has now been investigated by adding oncotically active macromolecules to the circulation of normal or genetically albumin-deficient Nagase analbuminemic rats (NAR) and analyzing the hepatic expression of genes, including albumin after 24 h. The transcription rate of the albumin gene was higher in NAR than in normal rats and was dramatically reduced by raising serum albumin to 1.6 g/dl. Intravenous infusion of albumin into normal rats also decreased transcriptional activity of the albumin gene by 50-60%, and this decrease correlated with changes in serum colloid osmotic pressure after albumin infusion. Inhibition ofalbumin gene transcription was also observed upon intravenous infusion of other protein or nonprotein macromolecules, such as y-globulin and dextran. This down-regulation appears to control the steady-state level of albumin mRNA in the liver. Aside from a concomitant decrease in apo E gene transcription after albumin or macromolecule infusion, there was no change in the transcription rate of other genes, including those exhibiting liver-preferred or -specific expression (e.g., tyrosine aminotransferase, cytochrome P450, a1-antitrypsin, apolipoproteins A-I and B, and transferrin) or general cellular expression (e.g., a-tubulin, pro a2 collagen, and fl-actin). Feedback The liver represents the main source of serum albumin (1, 2) . Normally, the plasma albumin concentration remains constant at 3.5-4.0 g/dl, suggesting an active regulation ofalbumin metabolism. Several pathophysiological studies have shown that hormones, malnutrition, and stress may influence albumin synthesis (3-7); however, little is known about the "physiological" regulator(s) of albumin or other proteins synthesized by the liver. Many years ago, Biorneboe (8, 9) observed that an increase in the serum concentration ofglobulins is followed by a concomitant decrease ofserum albumin in hepatitis and after immunization, and he proposed that the serum colloid osmotic pressure (COP)' might serve as a regulator for changes in serum protein concentration. In support ofthis hypothesis, hyperglobulinemia, infusion of y-globulin, and administration of dextran were also shown to decrease serum albumin levels (10) (11) (12) . Moreover, in a variety ofconditions in which serum albumin levels fall either acutely (e.g., plasmapheresis) or chronically (e.g., nephrotic syndrome), hepatic albumin synthesis is increased (13) (14) (15) .
In the 1960's, Rothschild et al. (16) demonstrated that addition of albumin to the perfusate medium ofthe isolated rabbit liver decreases incorporation of labeled amino acids into albumin. Other studies extended this observation to macromolecules other than albumin, and it was proposed that all these agents may work through a common feedback mechanism based on their ability to influence the COP (17, 18) . However, the molecular basis for this regulation has never been identified, and at present it is not known whether the proposed feedback regulation operates on albumin synthesis at the transcriptional, posttranscriptional, or translational level or on albumin secretion.
To test the hypothesis that serum colloids may affect the synthesis of albumin in the intact liver, we added oncotically active macromolecules to the circulation of normal SpragueDawley rats (SDR) or Nagase analbuminemic rats (NAR) and used a molecular approach to analyze expression of the albumin gene. Since NAR have virtually no albumin in the serum (19), and low serum COP (20) , analyses in both NAR and normal SDR would be useful in testing different aspects of albumin gene expression and its regulation in response to external manipulations. Expression of other specific genes, including those coding for unique liver functions, functions enriched in the liver but not unique, and common cellular or "housekeeping" functions, was also analyzed to determine the extent to which expression of these genes is influenced in vivo by albumin or other macromolecule infusion.
Methods
Male SDR and NAR (I180-200 g body wt) received, under ether anesthesia, a single transjugular injection of 3.5-4 mg/g body wt of rat serum albumin, dextran (mol wt -70 kD), or rat gamma-globulins (Sigma Chemical Co., St. Louis, MO) dissolved in 1-2 ml of saline. Control rats received 1-2 ml ofsaline alone under the same conditions. All solutions were passed through a bacterial filter (pore size 0.20 Mim; RFS, Dublin, CA) before injection. After 20-24 h, rats were killed by cardiac puncture under light ether anesthesia. Livers were removed quickly and perfused at 4VC with 50 ml ofa solution containing 0.25 M sucrose, 1 mM MgCl2, and 10 U/ml heparin. An aliquot of tissue was frozen in liquid nitrogen and stored at -800C until RNA extraction and RNA blot analysis. The remaining tissue was used for isolation of nuclei.
In vitro transcription in isolated nuclei ("run-on" assay). Nuclei were isolated by centrifugation through a sucrose gradient as previously described (21); however, the protocol for measuring the relative transcription rates of hepatic genes was modified slightly. Briefly, after isolating and labeling 20-40 X ltg/ml denatured salmon sperm DNA. Hybridizations were performed in the same solutions with 2-3 X 106 cpm/ml ofprobe for 20 h at 420C.
The DNA probes were labeled using a multiprimer labeling kit (Amersham, Searle Corp.), according to the manufacturers directions and [32P]dCTP (sp act 3,000 Ci/mmol), to obtain a sp act of 4.0-6.0 X I0O cpm/,ug DNA. After hybridization, filters were washed essentially as described above for the nuclear "run on" transcription assay. After washing, filters were exposed to autoradiography at -80'C on Kodak XAR-5 film, using intensifier screens (Lightening Plus; DuPont Co.). Quantitation ofresults was obtained by densitometry scanning ofautoradiograms as noted. RNA slot-blot. For some mRNA quantitation experiments, total RNA was applied directly to a nitrocellulose filter using a slot-blot hybridization apparatus (Schleicher & Schuell Inc.). 10 ug oftotal RNA was heat denatured at 65°C for 10 min in a solution containing 20X SSC and 37% formaldehyde (1:1, vol/vol) and applied to each slot. Experimental points were determined in duplicate. Hybridization and washing procedures, as well as quantitation of results, were as for Northern blot analysis. The advantage ofthe slot-blot method for RNA quantitation is that all specimens are applied to a geometrically fixed area on the filter and this makes it easier to compare hybridization signal produced by one sample versus another.
Biochemical andphysiological measurements. Albumin levels were measured in serum samples obtained from rats before and after albumin infusion by standard biochemical procedures (24) . Serum samples from analbuminemic rats were also analyzed by rocket immunoelectrophoresis. Dextran was determined with anthrone by the method ofRoe (25) and y-globulins by serum protein electrophoresis (26) . Serum COP was kindly measured by Dr. George Kaysen, University ofCalifornia, Davis, using a strain gauge microoncometer (Statham Instruments, Oxnard, CA).
Statistical analyses. Biochemical, physiological, and densitometric data are expressed as means±SD. Significant differences between mean values ofsaline control and macromolecule infused rats were evaluated using the t test. conditions. The transcription rate of the albumin gene was twofold higher in NAR than in normal SDR. The intravenous infusion of albumin in NAR decreased the albumin transcription rate significantly at 24 h after infusion (average decrease -60%). Transcription of the apo E gene, which was higher in NAR than in SDR under basal conditions, was also substantially reduced by albumin infusion in NAR. However, after albumin infusion, there was no significant change in the relative transcription rate of several other genes, including those coding for liver-specific functions (TAT and fibrinogen), liverenriched functions (apo B, apo A-I, and Tf), or general cellular functions (fl-actin, a2-coll, or a-tubulin).
Results
To determine whether albumin infusion could change the basal level of constitutive albumin gene expression in normal rats, SDR were infused intravenously with albumin. Fig. 2 shows an evident drop in albumin gene transcription, detectable 24 h after infusion of albumin. Quantitation of results obtained from three different experiments indicated a 50-60% decrease in the albumin transcription rate after albumin infusion in normal SDR (Table III) . As shown in Fig. 2 , the transcriptional activity of apo E is also lower in albumin-infused than in control animals (infused with saline). No significant change in the relative transcription rate of albumin was detected after administering < 1.5 mg/g body wt of serum albumin to either NAR or SDR (data not shown).
To test the specificity of the inhibitory effect of albumin infusion on albumin gene transcription, SDR rats were infused To test whether the steady-state level of albumin mRNA changed in concert with the transcription rate ofthe gene upon macromolecule infusion, accumulation ofalbumin transcripts was analyzed under control and experimental conditions. Representative examples of such experiments are shown in Fig. 4 . The infusion of serum albumin or dextran decreased by 50-60% the steady-state level ofalbumin mRNA (Fig. 4 and Table  II ), comparable to the change observed in the relative transcription rate of the albumin gene (Table II) . However, the relative transcription rate and mRNA steady-state level for a housekeeping gene (i.e., f3-actin, see Table III and Fig. 4 ) and the mRNA levels for acute-phase-related genes (e.g., ,3-fibrinogen and a,-AGP; see Fig. 4 ) were unchanged after macromolecule infusion.
In regard to other genes analyzed in this study, the transcription of only apo E was consistently down-regulated by 
Discussion
The main goal ofthis study was (21, 27) . Such a behavior of these two transcriptionally regulated genes may indicate a coordinate regulation at the molecular level, possibly due to structural homologies in the enhancer/promoter regions responsive to specific nuclear transcriptional factors. Recently, a well-known transcriptional activator (LF B-l/HNF-l), which interacts in a sequence-specific manner with the promoter of some liver-specific or -enriched genes, including f-fibrinogen (28) , has been found also to bind to a specific cis-element in the albumin promoter (element B) (29) . The element B and its cognate factor are known to play a dominant role in directing liver-specific expression ofthe albumin gene (30) . Thus, inhibition of specific expression by infused macromolecules may occur with other polymerase IItranscribed genes in addition to albumin. A well-documented circumstance in which albumin synthesis is subjected to negative regulatory control is during the acute-phase response (31) . As to the experimental manipulations used in the present study, the intravenous injection ofhigh molecular weight macromolecules may induce a "stress" response. However, this effect is transient; and our observation that neither the transcriptional activity nor the steady-state mRNA level oftwo representative acute phase reactants in rats (i.e., fibrinogen and a1-AGP) were increased at 24 h after macromolecule infusion rules out this possibility. In fact, although the major mediators of the acute-phase response, such as cytokines and glucocorticoids (32) , inhibit albumin synthesis, such a phenomenon is usually accompanied by a concomitant increase in the expression of "positive" acute phase genes, including fibrinogen and a1-AGP (33) , which was not observed. An additional control for acute phase effects was the infusion of saline into control animals and comparison to untreated animals after 24 h, with essentially no change in the relative transcription rate for albumin or other genes included in this study.
Our data suggest transcriptional down-regulation as the molecular basis for inhibition of albumin synthesis by albumin, dextran, or y-globulin infusion (1 1-13, 16-18 ). The nature of the signal responsible for this apparent feedback regulation is at present unknown. An attractive possibility, supported by our data, is that the specific modulatory signal is mediated by changes in the COP that result from fluctuations in the serum or plasma level of albumin or other colloids. As originally proposed by Rothschild et al. (16) , such a colloid-mediated regulatory mechanism is presumably localized within the liver, perhaps in the interstitial space (i.e., space ofDisse) (34) . However, in this region ofthe liver, the effective COP is thought to be low (35) , and the actual concentrations of colloids in Disse's space may not reflect their concentration in the circulation. In fact, in addition to the barrier exerted by liver sinusoids to the passage of very large macromolecules (36) , the bulk of interstitial fluid is occupied by a protein-polysaccharide matrix, which causes an uneven distribution ofproteins; and part ofthe fluid in the hepatic interstitial space is itself excluded to proteins (37) (38) (39) .
It is also known that infusion of high molecular weight compounds displaces albumin from the intravascular space toward the interstitial spaces (34) . Thus, infusion of other proteins, such as y-globulin, could induce an altered distribution ofcirculating albumin, thereby exerting an oncotic effect in the liver interstitial space higher than that predicted on the basis of their mass or serum concentration. All these factors could result in a detectable effect on hepatic gene activity, even when there are only limited changes in the actual serum concentration of infused macromolecules or COP after infusion.
Aside from the COP, other factors may also be involved in feedback regulation of albumin synthesis. Vasopressin, a vasoactive nonapeptide produced by the posterior pituitary, has been found capable of decreasing albumin mRNA levels in primary cultures of rat hepatocytes (40) . It appears unlikely, however, that such an osmotically regulated substance might be released upon infusion of macromolecules, which are known to account for < 0.5% of total plasma osmolarity (41) .
In contrast, a change in plasma volume with subsequent release of other peptides, such as the atrial natriuretic peptides (atriopeptins), is more likely to occur after albumin or dextran infusion (42) . Atriopeptins act in an integrative manner on a number of target organs to modulate cardiovascular function and fluid balance. Recently, a modulatory activity of atriopeptins on vasopressin release from the hypophysis has been proposed (43) . The interplay of these vasoactive peptides on a systemic basis may, therefore, influence the metabolic function of specific organs, as recently suggested for volume regulatory responses modulating hepatic ammonia metabolism (44) . However, since an inhibitory effect on albumin synthesis by colloids has also been described in ex vivo systems (16) (17) (18) (47) (48) (49) . Studies are now in progress to identify specific 5' upstream sequences in the albumin gene that confer the regulatory response to this novel feedback regulatory mechanism.
